CN Patent

CN101616915B — 调控激酶级联的组合物以及方法

Assigned to Anzix Special Purpose Co ltd · Expires 2014-12-17 · 11y expired

What this patent protects

本发明涉及N-苯甲基-2-(5-(4-(2-吗啉基乙氧基)苯基)吡啶-2-基)乙酰胺(KX2-391)的组合物以及调控激酶级联的一种或者多种成员的方法。

USPTO Abstract

本发明涉及N-苯甲基-2-(5-(4-(2-吗啉基乙氧基)苯基)吡啶-2-基)乙酰胺(KX2-391)的组合物以及调控激酶级联的一种或者多种成员的方法。

Drugs covered by this patent

Klisyri (TIRBANIBULIN) · Almirall

Patent Metadata

Patent number: CN101616915B
Jurisdiction: CN
Classification: —
Expires: 2014-12-17
Drug substance claim: No
Drug product claim: No
Assignee: Anzix Special Purpose Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.